Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors (Q56959455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Ian Frazer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Koji Matsumoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jie Zhong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Xiaosong Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Rachel L de Kluyver

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Tania Peters

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Germain J P Fernando

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Amy Liem

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Paul F Lambert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

1611-1619

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

A listing of human tumor antigens recognized by T cells

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Introduction: current concepts in immunity to human cancer and therapeutic antitumor vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Prevention of cervical cancer through papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

The number of long-lasting functional memory CD8+ T cells generated depends on the nature of the initial nonspecific stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Cross-presentation: a general mechanism for CTL immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

T cell tolerance to a neo-self antigen expressed by thymic epithelial cells: the soluble form is more effective than the membrane-bound form

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

CD4 T cells and their role in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH301

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/EJI.1830230929

Identifiers

DOI

10.1093/JNCI/DJH301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15523090%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference